Here are relevant reports on : lymphedema-diagnostics-therapeutics-market
-
Companion Diagnostics Market - 2019 By Types, Application & Geography
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Epigenetic Drugs & Diagnostics Market - Global Forecast to 2030
Epigenetic Drugs & Diagnostics Market
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
ECU Diagnostics and Testing Market - Global Forecast to 2032
The ECU diagnostics and testing market is projected to grow from USD 18.0 billion in 2025 to reach USD 28.6 billion by 2032. Increasing popularity of hybrid & electric vehicles with complex electrical architectures, increase in demand for advanced features such as ADAS systems for vehicle safety, and rise in demand for in-vehicle experience with entertainment in the vehicle is driving the demand for ECU diagnostics and Testing market during the forecast period.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Diagnostics-as-a-Service Market 2032: Size, Share & Growth Report
The global diagnostics-as-a-service market was valued at an estimated USD 5.40 billion in 2025 and is projected to reach USD 18.35 billion by 2032, growing at a CAGR of 19.0% between 2026 and 2032.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Construction & Mining Fleet Management Market by Solution (Operations Management, Battery Maintenance & Diagnostics, Performance Management, Fleet Analytics & Reporting), Fleet Type (Passenger Cabs, Commercial, Public Transport) - Global Forecast to 2030
The construction & mining fleet management market is projected to reach USD 7.28 billion by 2030, growing from USD 4.04 billion in 2025 at a CAGR of 12.5% during the forecast period. The key players include Caterpillar (US), Komatsu (Japan), Volvo (Sweden), Samsara (US), Wenco (Canada), Hexagon (Sweden), Sandvik (Sweden), RPMGlobal (Australia), Verizon Connect (US), Teletrac Navman (US), JCB (UK), Liebherr (Switzerland), CNH Industrial America (US), Geotab (Canada), and Epiroc (Sweden).
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Middle East & Africa In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Infectious Disease) - Forecast to 2031
The Middle East & Africa in vitro diagnostics (IVD) market, valued at USD 3.33 billion in 2025, stood at USD 3.49 billion in 2026 and is projected to advance at a resilient CAGR of 4.8% from 2026 to 2031, culminating in a forecasted valuation of USD 4.42 billion by the end of the period.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Womens Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care) & Region - Global Forecast to 2025
The global womens health diagnostics market growth is primed to transition from $25.0 billion in 2020 to $36.6 billion by 2025, showcasing a strong CAGR of 7.9%. The market growth is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Early Toxicity Testing Market by Technique (In-vivo, In-vitro, & In-Silico), End-user (Pharmaceutical, Diagnostics, Food, Chemicals, Cosmetics, & Others), Trend & Global Forecast to 2019
Toxicity is an extent to which a particular substance can damage the living organism; it is important parameter to be evaluated during all stages of drug development. Toxicity testing is conducted to determine the degree to which a substance can damage a living or non-living organism. Owing to the higher rejection rate of drug in the recent years citing high toxicity level, the companies have started using toxicity testing in drug discovery
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Blood Glucose Monitoring Devices Market by Product [Blood Glucose Meters, Continuous Glucose Monitoring Systems (Sensors, Transmitter), Glucose Monitoring Strips, Lancets], Application (Hospitals, Diagnostics, Home Settings) - Global Forecasts to 2019
The global blood glucose monitoring devices market is expected to grow at a significantly high rate in the next five years. Global rise in the prevalence and incidence of diabetes and increasing adoption of continuous glucose monitoring (CGM) systems are the key factors propelling the growth of this market. In addition, continuous technological advancements in blood glucose monitoring devices and rapid growth in aging population are further stimulating the demand for blood glucose monitoring devices. However, inadequate reimbursement and high cost associated with the application of CGM systems and product recalls are some of the key factors hampering the growth of this market.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Glycomics Market / Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User - Global Forecast to 2027
The global glycomics market in terms of revenue was estimated to be worth $1.8 Billion in 2022 and is poised to reach $3.7 billion by 2027, growing at a CAGR of 15.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
